Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1967-9-7
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0001-6284
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
66
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
771-6
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:4961572-Adult,
pubmed-meshheading:4961572-Aged,
pubmed-meshheading:4961572-Clinical Trials as Topic,
pubmed-meshheading:4961572-Female,
pubmed-meshheading:4961572-Humans,
pubmed-meshheading:4961572-Male,
pubmed-meshheading:4961572-Middle Aged,
pubmed-meshheading:4961572-Parasympatholytics,
pubmed-meshheading:4961572-Parkinson Disease
|
pubmed:year |
1966
|
pubmed:articleTitle |
Preliminary report on a new anti-Parkinson drug, UCB 1549.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|